From the website 17/12, page-26

Looks good for a phase 1
No side effects/adverse effects and no increase in tumours
It says it’s an explatorary trial in response
Obviously they are still getting dosing levels right being they did 3 different doses
So if they are using different doses and not really getting an increase in tumours or side effects that seems pretty good
The high/doses maximum doses down the track will be of interest

Nearly all immuno trials I follow are in combo with chemo that seems the standard line of treatment (and also with surgery) and all bios are reporting the same way in combo chemo treatment results wise so I don’t think you can single them out with this reports for that specifically